|
HS Code |
246860 |
| Name | Ginsenoside Rf |
| Chemical Formula | C42H72O14 |
| Molecular Weight | 801.01 g/mol |
| Cas Number | 52286-59-6 |
| Iupac Name | (3β,6α,12β,20S,24R)-dammar-24-ene-3,6,12,20-tetrol 3-[O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside] |
| Appearance | White to off-white powder |
| Solubility | Soluble in methanol and ethanol; poorly soluble in water |
| Source | Extracted from Panax ginseng (root) |
| Stability | Stable under recommended storage conditions |
| Storage Conditions | Keep in cool, dry place; avoid light |
| Purity | Typically >98% (HPLC) |
| Melting Point | 220-225°C |
As an accredited Ginsenoside- Rf factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ginsenoside-Rf is packaged in a 10 mg amber glass vial with a tamper-evident seal, labeled with product details and purity. |
| Shipping | Ginsenoside-Rf is shipped in tightly sealed containers, protected from light, moisture, and extreme temperatures. It is packed according to chemical safety regulations, often with cushioning material and clear hazard labeling. Shipping documentation includes product identification, handling instructions, and safety data, ensuring secure and compliant delivery to the recipient. |
| Storage | Ginsenoside-Rf should be stored in a tightly sealed container, protected from light, moisture, and air. It is best kept at -20°C in a dry, cool environment to maintain stability and prevent degradation. Avoid repeated freeze-thaw cycles. Label clearly and restrict access to qualified personnel. Follow all standard laboratory protocols for storage of sensitive chemicals. |
Competitive Ginsenoside- Rf prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Producing natural compounds calls for more than technical know-how; it draws on patience, experience, and an unwavering commitment to quality. Among the broad spectrum of ginsenosides, Ginsenoside-Rf stands out due to its unique molecular profile and growing applications across the health and pharmaceutical industries. Over years of working directly with Panax ginseng extracts, our production lines have seen an increase in demand for Ginsenoside-Rf, especially after research began linking its distinct structure to neuroprotective and anti-inflammatory activities.
A reliable supply of pure Ginsenoside-Rf comes down to understanding raw material differences. A seasoned manufacturer knows that root age, careful harvesting, and handling methods all impact the ginsenoside composition. Many new industry partners overlook these details, relying on generic specifications. Yet, controlling farming and processing conditions yields a consistent Rf content, one we can chart and optimize year after year. Differences show up even in small changes — for example, ginseng harvested one season later often carries more minor saponins, subtly influencing Rf distribution in our extractions.
Once ginseng roots reach the optimal age, processing starts with gentle drying to avoid unwanted degradation. Overheating or moisture swings promote breakdown, which leads to poorer yields. Extracting Ginsenoside-Rf demands close monitoring of temperature and solvent ratios; deviations quickly shave off purity points. Our team relies not just on computer controls but firsthand experience — recognizing the aroma and color shifts that signal process progress. Each extraction batch undergoes multiple passes using columns calibrated to target Rf’s polarity, keeping contaminants low.
We routinely select chromatographic methods that balance speed and selectivity. High-performance liquid chromatography (HPLC), especially using gradient elution, is the backbone of our purification. This method lets us recover Rf with high selectivity, preventing overlap with neighboring ginsenosides like Re or Rg1. These practical details shape the outcome as much as any official method description ever could. The resulting concentrate often exceeds 98% purity for research-grade requirements, and our team validates each batch both through HPLC and mass spectrometry to cross-confirm molecular integrity.
We offer several grades of Ginsenoside-Rf to fit both research and industrial applications. Our standard models fall under two groups: analytical grade and bulk grade. The analytical version undergoes additional recrystallization, resulting in a finer powder with minimal moisture and trace impurity content. It works well for laboratories needing accurate calibrations or mechanistic studies. Bulk grade retains a slightly coarser form and marginally broader spectrum of related ginsenosides. This suits industrial blending into complex formulations, where the matrix itself buffers minor components.
Tailoring particle size forms a core part of our approach. Analytical lots usually fall between 100 and 200 mesh, yielding rapid dissolution for testing, whereas bulk runs may range up to 80 mesh for easier handling in manufacturing. Each model presents specific strengths: finer lots dissolve in solvents in seconds, while coarser granules reduce dust in high-volume workflows. Through direct collaboration, we’ve even produced custom intermediates, developed according to partners’ blending or encapsulation practices. In these discussions, practical experience shapes what works — not just what looks good on a technical sheet.
Moisture content is another practical consideration. Overly dry powders absorb humidity in open air; high water content clumps during storage. Achieving a balance, we finish each lot at around 2% residual water, proven stable through both summer and winter logistics. Beyond pure Rf, we sometimes supply standardized extracts where Rf forms a major component, paired with other saponins for synergistic effects. Flexibility exists for those with unique requirements, especially when developing new delivery systems for nutritional or medical use.
Having supplied Ginsenoside-Rf for well over a decade, its roles have shifted as scientific understanding deepened. Years ago, most of it went to academic studies exploring the distinct pharmacology of rare ginsenosides. Today, the conversation leans toward forms optimized for bioavailability and integration into wellness supplements. Pharmaceutical developers often request high-purity Rf for preclinical trials, focusing on its modulation of neuroinflammation and cognitive support. Their teams frequently report improved solubility and stability compared to other ginsenosides, reducing formulation headaches.
Dietary supplement manufacturers take a somewhat different approach. They often value a balanced spectrum of ginsenosides, but include isolated Rf to differentiate premium blends. Practical feedback received over the years points to its better tolerance profile, avoiding some of the harshness seen with higher Rg3 or Rd concentrations. In a final product, consistent supply matters even more than headline purity. That’s where our comprehensive production controls reinforce their launches, cutting the downtime and batch-to-batch surprises that delay so many projects.
Experience teaches that no two ginsenosides behave the same under processing or real-world usage. Ginsenoside-Rf, with its unique dammarane-type skeleton and additional glycosidic branches, resists hydrolysis more than its close relatives like Rg1 or Re. In extraction, this resilience means Rf remains intact throughout longer, more demanding steps. Technicians handling Rf in a plant notice its smoother solubility curve, even as process variables shift.
Practical effects show up in tablets and capsules. For instance, Rg3 often shortens product shelf-life due to its chemical lability. Rf, on the other hand, maintains stability under both high heat and light exposure, opening up uses in formats not available to more fragile saponins. In functional food applications, such as fortified beverages or bars, Rf’s less bitter taste profile stands out. Over years, developers switching to Rf from Rc or Rd have cut costs on masking agents and improved customer feedback. This fact rarely gets attention in technical documentation, but proves material during product launches.
Ginsenoside-Rf also influences cell transport and absorption differently. Some studies highlight its ability to bypass the blood-brain barrier more effectively, a trait leveraged by researchers examining cognitive support. We confirmed early this trend by noting demand spikes from clients working on neurological supplements or cognitive aids. Re, by contrast, demonstrates more cardiovascular orientation, making the selection of each ginsenoside critical to final product positioning.
A credible ginsenoside operation always puts traceability at the forefront. Tracking Rf starts with seed lot documentation, verifying Panax ginseng origins and farming methods. Though commodity traders rarely visit fields themselves, we regularly audit farms and drying facilities, favoring age-old fermentation methods proven to yield higher Rf. This hands-on control helps avoid the cross-contamination and misleading labeling problems that occasionally surface in the global market.
Tight process oversight carries through extraction and all the way to final packing. Each step creates a reference checkpoint; any deviation in solvent residue, color, or purity gets flagged before shipping. This approach has evolved from countless feedback loops with partners relying on us for regulatory submissions and audits. Most recall the confusion and lost batches that stem from poorly labeled intermediates. Our traceability program reduces these headaches. In routine tests, we cross-check for adulteration, particularly for dyes and synthetic glycosides known to falsify analytical readings.
Ginsenoside-Rf, by virtue of its natural origin and historical consumption in Asian herbal medicine, carries a track record of general safety. Laboratory extraction does concentrate it far beyond traditional usage, raising questions among regulatory bodies about long-term safety and appropriate dosing. We keep up with toxicology reports and encourage transparent reporting for any side effects seen in both pre-clinical and early trial phases. Unanticipated interactions with pharmaceuticals do occur, typically flagged by partners at the development stage — reinforcing the need for detailed batch analysis before market launches.
Storage and handling safety receive equal attention. Fine powders of purified Rf are free-flowing and produce little dust under controlled humidity, allowing safe transfer even in high-volume operations. Our facilities place strong emphasis on closed systems; open transfers invite air-borne contamination and unnecessary worker exposure, points often underestimated during scale-up. We encourage partners to adopt similar safeguards, derived from hard-earned experience rather than theoretical advice.
The push for higher-purity Rf means ongoing troubleshooting. Ginseng, as a biological raw material, produces different ginsenoside profiles from year to year — rain patterns, temperature swings, and soil microflora each shift the balance. Our plant runs extra chromatography checks after storm-heavy seasons, adjusting parameters to recover Rf yields from slightly altered starting material. Starting operators on mandatory cross-training helps the team handle these variables, so we can solve issues before they grow into supply gaps.
Scaling is another recurring challenge. What works flawlessly in a 5-liter test reactor often hits limits during 200-liter production. Heat transfer, filter clogging, or batch stratification all bring lessons only learned through repetition. Regular maintenance and investment in modular equipment have enabled rapid response to process hiccups, a distinct benefit for long-term supply agreements. This practical flexibility ensures confidence on both sides of the supply chain — a factor never captured fully in off-the-shelf product summaries.
True product development rarely happens in isolation. Over the years, close feedback with downstream partners has shaped the properties of Ginsenoside-Rf we now provide. Supplement formulators occasionally push back on powder flow or blending challenges — these drive incremental improvements in moisture control and particle size. Pharmaceutical teams request ever-purer Rf lots for clinical work, pressing us to explore new purification chemistries. Each improvement is logged, validated, and then rolled into routine production after internal verification. This iterative approach keeps our Rf at the forefront, matching the evolving standards of the industries it serves.
Market demand sometimes sends sudden signals for higher capacity or different formats, such as microencapsulated Rf for sustained-release products. Instead of rigidly sticking to older schedules, our production calendar flexes, balancing high-volume generic lots with bespoke batches. The feedback process often uncovers efficiency improvements first seen on the shop floor rather than in corporate analyses.
Purity sets the foundation for Rf’s performance in finished products, and with it comes a need for rigorous authentication. Advancements in mass spectrometry and nuclear magnetic resonance have set new standards in trace detection of side compounds. Each Rf lot ships with a comprehensive fingerprint — customers gain confidence knowing that targeted Rf profile matches what we confirm internally. The rise of counterfeit and adulterated extracts in the global market makes this assurance vital; on several occasions, we've tracked mislabeled lots failing third-party validation, a costly error avoided through a transparent authentication process.
On the plant floor, authenticity means more than lab techniques. It demands seeing each production run from raw material to final packing, discouraging the temptation to cut corners in haste. Successful long-term relationships with Rf buyers stem from this philosophy — clear, verifiable, and cooperative control over the entire value chain.
Emerging technologies in extraction and purification hold promise for making Rf more accessible. Supercritical fluid extraction, for instance, cuts down solvent requirements while preserving heat-sensitive saponins other processes would degrade. We continually trial these tools in side projects, sharing findings with industry partners able to scale up new methods. Waste reduction remains another priority. Rf fractionated from industrial by-products or using enzyme-assisted hydrolysis can recover yields previously lost, turning secondary streams into valuable revenue sources. Insights from years of hands-on production underscore that no innovation stands still in a vacuum.
Eco-friendly manufacturing isn't buzz — it’s necessity. Ginseng cultivation puts pressure on land and water. Our company invests in soil recovery, limiting monoculture cycles and working with growers who rotate plots. Onsite water treatment ensures solvents never seep into groundwater, safeguarding communities living near our production sites. Reducing energy use during evaporation and concentration steps directly lowers our carbon emissions, with regular audits to chart progress. These details matter not as marketing points but as long-term investments, shaping both the raw materials and the communities we depend upon.
Decades of experience have shaped our approach to Ginsenoside-Rf. Detailed knowledge of sourcing, process, and final usage provides not just a product but a running partnership with those pushing the boundaries of research, supplements, and healthy living. Every improvement, every adjustment serves a central promise: delivering Rf with clarity, predictability, and an open door to feedback. As research diversifies and regulatory standards tighten, this practical, experience-based trust remains our most valuable asset.